BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TRAF7, DKFZp586I021, 84231, ENSG00000131653, RNF119, MGC7807, Q6Q0C0, RFWD1 AND Treatment
7 results:

  • 1. Meningioma: current updates on genetics, classification, and mouse modeling.
    Szulzewsky F; Thirimanne HN; Holland EC
    Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
    Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
    J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Loss-of-Function Mutations in traf7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development.
    Najm P; Zhao P; Steklov M; Sewduth RN; Baietti MF; Pandolfi S; Criem N; Lechat B; Maia TM; Van Haver D; Corthout N; Eyckerman S; Impens F; Sablina AA
    Cancer Res; 2021 Aug; 81(16):4218-4229. PubMed ID: 34215617
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Associations of meningioma molecular subgroup and tumor recurrence.
    Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
    Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
    Martinez NL; Khanna O; Farrell CJ
    Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High-grade meningiomas: biology and implications.
    Bi WL; Prabhu VC; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
    Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
    Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.